Skip to content
Beacon

IBRNiShares Neuroscience and Healthcare ETF

Grow my money4y track recordRanked #2,228 of 3,055 in this goal

Tracks the investment results of the NYSE FactSet Global Neuro Biopharma and MedTech Index.

By iShares · Launched 2022

Annual Cost

0.47%

#2,464 of 6,040 · average

Fund Size

$8M

#5,107 of 6,040 · small

Return (1Y)

+44.6%

Track Record

4 years

#2,708 of 6,040 · seasoned

Performance

Total-return NAV · USD
Growth of $10,000
$14,385+43.9%

Total-return NAV, USD. Net of fund fees, before tax.

What's inside

How Beacon categorizes this fund

Asset class

Equity

Region

Global

Cap

Multi cap

Strategy

Index tracking

Sector

Health care

Focus

Medical Devices

Index tracked

NYSE FactSet Global Neuro Biopharma and MedTech Index

Holdings

By weight

Concentration

Top 10 holdings = 45.4% of fundmoderately concentrated

BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares
8.6%
Xenon Pharmaceuticals Inc
4.8%
AXSOME THERAPEUTICS, INC.
4.6%
ARROWHEAD PHARMACEUTICALS, INC.
4.4%
ALKERMES PUBLIC LIMITED COMPANY
4.2%
CENTESSA PHARMACEUTICALS PLC
4.0%
argenx SE
3.9%
PTC THERAPEUTICS, INC.
3.7%
NEUROCRINE BIOSCIENCES, INC.
3.7%
BIOGEN INC.
3.7%

Asset allocation

Stocks
99.9%
Cash
0.1%

By sector

Healthcare
100.0%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
25.9%High

Year-on-year price swings

Max drawdown
-35.4%Severe

Worst peak-to-trough loss

Sharpe (3Y)
0.62Decent risk-adjusted returns
Sortino (3Y)
0.90Moderate downside risk

Listing

Exchange
NYSE Arca

Full fund details

Objective
Tracks the investment results of the NYSE FactSet Global Neuro Biopharma and MedTech Index.
Strategy
Invests primarily in equity securities of U.S. and non-U.S. companies involved in neurology biopharmaceuticals and neurological devices. The Fund seeks to track the NYSE FactSet Global Neuro Biopharma and MedTech Index, which includes large-, mid-, and small-cap companies across various countries.
Inception date
August 24, 2022
Fund family
iShares

Next steps

Save IBRN to compare it with other funds, or start building a portfolio.

See other funds for this goal

Data updated on 2026-09-18